**Core Concept**
The Hexose Monophosphate (HMP) shunt, also known as the Pentose Phosphate Pathway (PPP), is a metabolic pathway that generates NADPH and pentoses from glucose-6-phosphate. This pathway is crucial for producing reducing power in the form of NADPH, which is essential for various cellular processes, including fatty acid synthesis, cholesterol synthesis, and antioxidant defenses.

**Why the Correct Answer is Right**
In the oxidative phase of the HMP shunt, glucose-6-phosphate is converted into ribulose-5-phosphate, generating NADPH in the process. This is achieved through the action of two key dehydrogenases: glucose-6-phosphate dehydrogenase (G6PD) and 6-phosphogluconate dehydrogenase (6PGD). G6PD catalyzes the conversion of glucose-6-phosphate to 6-phosphogluconolactone, producing NADPH, while 6PGD converts 6-phosphogluconolactone to ribulose-5-phosphate, further generating NADPH. The NADPH produced in the oxidative phase is then used to drive downstream reactions in the HMP shunt.

**Why Each Wrong Option is Incorrect**
**Option A:** NADP+ is the oxidized form of NADPH and is not directly generated in the oxidative phase of the HMP shunt. Instead, NADP+ is reduced to form NADPH.

**Option C:** FAD+ is the oxidized form of FADH2, which is not directly involved in the oxidative phase of the HMP shunt. FADH2 is primarily associated with the electron transport chain and fatty acid oxidation.

**Option D:** FADH is not a correct abbreviation for a reduced or oxidized form of FAD. The correct abbreviations are FADH2 (reduced) and FAD (oxidized).

**Clinical Pearl / High-Yield Fact**
A deficiency in glucose-6-phosphate dehydrogenase (G6PD) can lead to hemolytic anemia, particularly in individuals exposed to oxidative stressors such as certain medications, infections, or foods. This is because G6PD is essential for protecting red blood cells from oxidative damage.

**✓ Correct Answer: B. NADPH**